Colossal Biosciences has 6 close competitors: Formation Bio, Insitro, Retro Biosciences.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
Colossal BiosciencesFormation BioInsitroAtomwiseBenevolentAIEcovativa DesignAmerican biotechnology and genetic engineering company working on de-extinction of species such as the woolly mammoth, thylacine and dodo, and on conservation genetics.
Colossal Biosciences competes with 6 companies here: Formation Bio, Insitro, Retro Biosciences, Atomwise, BenevolentAI, Ecovativa Design.
Colossal Biosciences was last valued at $25B (rumored, Jul 2026). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
Lead investors for each round are in the funding timeline.
The closest biotechnology peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Colossal Biosciences is a private company; its shares do not trade on a public exchange.
The last valuation is $25B (rumored, Jul 2026).
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
